Basics |
Orthofix Medical Inc.
Orthofix International NV is a medical device company. It focuses on providing reconstructive and regenerative orthopedic and spine solutions to physicians.
|
IPO Date: |
April 24, 1992 |
Sector: |
Healthcare |
Industry: |
Health Care Equipment and Supplies |
Market Cap: |
$450.19M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.48 | 1.46%
|
Avg Daily Range (30 D): |
$0.17 | 1.34%
|
Avg Daily Range (90 D): |
$0.25 | 1.61%
|
Institutional Daily Volume |
Avg Daily Volume: |
.13M |
Avg Daily Volume (30 D): |
.35M |
Avg Daily Volume (90 D): |
.22M |
Trade Size |
Avg Trade Size (Sh.): |
89 |
Avg Trade Size (Sh.) (30 D): |
57 |
Avg Trade Size (Sh.) (90 D): |
51 |
Institutional Trades |
Total Inst.Trades: |
2,541 |
Avg Inst. Trade: |
$1.36M |
Avg Inst. Trade (30 D): |
$.66M |
Avg Inst. Trade (90 D): |
$.84M |
Avg Inst. Trade Volume: |
.05M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.24M |
Avg Closing Trade (30 D): |
$.66M |
Avg Closing Trade (90 D): |
$.7M |
Avg Closing Volume: |
47.02K |
|
|
|
|
News |
Apr 10, 2025 @ 5:30 AM
Intramedullary Nail Market size to worth USD 1,537...
Source: Coherent Market Insights
|
Feb 28, 2025 @ 3:56 PM
Prosthetic Disc Nucleus Market Outlook to Exceed U...
Source: Transparency Market Research Inc.
|
Nov 8, 2024 @ 9:00 PM
OFIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Oct 30, 2024 @ 1:00 AM
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Inv...
Source: N/A
|
Oct 28, 2024 @ 8:00 PM
OFIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-3.69
|
$-1.35
|
$-.75
|
Diluted EPS
|
$-3.69
|
$-1.35
|
$-.75
|
Revenue
|
$ 804.53M
|
$ 193.65M
|
$ 215.66M
|
Gross Profit
|
$ 540.26M
|
$ 121.62M
|
$ 148.84M
|
Net Income / Loss
|
$ -143.07M
|
$ -53.09M
|
$ -29.15M
|
Operating Income / Loss
|
$ -104.16M
|
$ -48.87M
|
$ -11.48M
|
Cost of Revenue
|
$ 264.27M
|
$ 72.03M
|
$ 66.82M
|
Net Cash Flow
|
$ 31.15M
|
$ -25.78M
|
$ 54.08M
|
PE Ratio
|
|
|
|
|